AJR Am J Roentgenol

1. FERRAIOLI G, Roccarina D, Barr RG
   Reply to "The Use of Ultrasound Attenuation Measurements to Evaluate Hepatic Steatosis".
   AJR Am J Roentgenol. 2025 May 7. doi: 10.2214/AJR.25.33189.
   

   >> Share

   
   
2. BLUTH EI
   The Use of Ultrasound Attenuation Measurements to Evaluate Hepatic Steatosis.
   AJR Am J Roentgenol. 2025 May 7. doi: 10.2214/AJR.25.33154.
   

   >> Share

   
   

   
   Am J Gastroenterol

3. PACHISIA AV, Agarwal A, Mehta S, Kumari A, et al
   Celiac Disease Is Common in Adults With Cryptogenic Cirrhosis and Responds Favorably to Gluten-Free Diet.
   Am J Gastroenterol. 2024 Nov 26. doi: 10.14309/ajg.0000000000003244.
   

   >> Share

   
   
4. SOUZA M, Al-Sharif L, Diaz I, Khalil SM, et al
   Enrollment in Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials: A Pooled Analysis of Screen Failure Rates.
   Am J Gastroenterol. 2025 May 5. doi: 10.14309/ajg.0000000000003520.
   

   >> Share

   
   

   
   Am J Pathol

5. RODEMANN MM, Dreschmann V, Dorner E, Sommer A, et al
   Identification of a growth-promoting gene cluster in the region 2q24 as a driver of tumorigenesis in childhood hepatoblastoma.
   Am J Pathol. 2025 Apr 30:S0002-9440(25)00147.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

6. AI R, Tian M, Sun J, He S, et al
   Mogroside V prevents ethanol-induced hangover and liver damage by reducing oxidative stress, steatosis and inflammation.
   Biochem Biophys Res Commun. 2025;766:151912.
   

   >> Share

   
   

   
   BMC Cancer

7. YALIKUN K, Li Z, Zhang J, Chang Z, et al
   Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial.
   BMC Cancer. 2025;25:838.
   

   >> Share

   
   

   
   BMC Gastroenterol

8. LYU S, Yang J, Xin X, Sun Q, et al
   Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease.
   BMC Gastroenterol. 2025;25:334.
   

   >> Share

   
   
9. YANG X, Ma J, Li H
   Trajectories of depressive symptoms and risk of chronic liver disease: evidence from CHARLS.
   BMC Gastroenterol. 2025;25:338.
   

   >> Share

   
   
10. SUN H, Cao Z, Zhao B, Zhou D, et al
    An elevated percentage of CD4(+)CD25(+)CD127(low) regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy.
    BMC Gastroenterol. 2025;25:340.
    

    >> Share

    
    
11. IMOTO K, Goya T, Azuma Y, Hioki T, et al
    Strain elastography for detecting advanced Fontan-associated liver disease: a retrospective study.
    BMC Gastroenterol. 2025;25:341.
    

    >> Share

    
    
12. PENG H, Zheng T, Zeng N, Han Y, et al
    Association of alkaline phosphatase to albumin ratio with all-cause mortality in critically ill patients with cirrhosis: a retrospective study.
    BMC Gastroenterol. 2025;25:339.
    

    >> Share

    
    
13. TIAN Y, Ma L, Liu S, Bai X, et al
    The prognostic value of AST-lymphocyte ratio index in liver cancer patients treated with TACE: a systematic review and single-center retrospective study.
    BMC Gastroenterol. 2025;25:348.
    

    >> Share

    
    

    
    Clin Res Hepatol Gastroenterol

14. LI Y, Ma XM, Jia JG, Cao LY, et al
    Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A Prospective Cohort Study.
    Clin Res Hepatol Gastroenterol. 2025 Mar 15:102573.
    

    >> Share

    
    
15. KHALIL SM, de Souza MHG, de Oliveira FD, Sato EDBS, et al
    Efficacy and safety of aldafermin for the treatment of metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2025;49:102579.
    

    >> Share

    
    
16. VILLAVICENCIO EA, Serdjebi C, Maldonado A, Ochoa Mora E, et al
    Use of Hepatoscope 2DTE for non-invasive assessment of liver stiffness among Mexican immigrant adults in a community-based setting.
    Clin Res Hepatol Gastroenterol. 2025;49:102581.
    

    >> Share

    
    
17. YANG LL, Chen X, Huang KT, Tang ST, et al
    BEND3 promotes hepatocellular carcinoma progression and metastasis by activating the PI3K/AKT/mTOR pathway and inducing epithelial-mesenchymal transition.
    Clin Res Hepatol Gastroenterol. 2025;49:102582.
    

    >> Share

    
    

    
    Dig Dis Sci

18. PASTA A, Pieri G, Plaz Torres MC, Missale G, et al
    Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2025 May 3. doi: 10.1007/s10620-025-09064.
    

    >> Share

    
    

    
    Endoscopy

19. NAGASHIMA K, Yamaguchi S, Maki R, Urushibara F, et al
    Confirmation of endoscopic injection sclerotherapy by mucosal whitening in the treatment of hemorrhage of refractory recurrent tiny esophageal varices.
    Endoscopy. 2025;57.
    

    >> Share

    
    

    
    Eur Radiol

20. WU Y, Ye Z, Yang T, Yao S, et al
    Preoperative prediction of early recurrence in hepatocellular carcinoma using simultaneous multislice diffusion kurtosis imaging.
    Eur Radiol. 2025 May 6. doi: 10.1007/s00330-025-11633.
    

    >> Share

    
    

    
    Gastrointest Endosc

21. SHUKLA A, Ingle M, Pandey V, Patra BR, et al
    Exploring the utility of EUS in Budd-Chiari syndrome: a multicenter multiobserver prospective cohort study.
    Gastrointest Endosc. 2024;99:817-821.
    

    >> Share

    
    
22. PFISTERER N, Riedl F, Schwarz M, Simbrunner B, et al
    Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last two decades.
    Gastrointest Endosc. 2025 May 3:S0016-5107(25)01639.
    

    >> Share

    
    

    
    Hepatology

23. GENG Y, Schwabe RF
    Hepatic stellate cell heterogeneity: Functional aspects and therapeutic implications.
    Hepatology. 2025 May 8. doi: 10.1097/HEP.0000000000001386.
    

    >> Share

    
    
24. WANG D, Yi S, Liu X
    Letter to the editor: Survival benefit of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors as conversion therapy for unresectable hepatocellular carcinoma needs more details.
    Hepatology. 2025 May 8. doi: 10.1097/HEP.0000000000001390.
    

    >> Share

    
    
25. O'ROURKE CJ, Andersen JB
    Intrahepatic Cholangiocarcinoma PANoptosidy.
    Hepatology. 2025 May 8. doi: 10.1097/HEP.0000000000001398.
    

    >> Share

    
    

    
    J Comput Assist Tomogr

26. LI YH, Qian GX, Zhu Y, Lei XD, et al
    An Integrated Model Combined Conventional Radiomics and Deep Learning Features to Predict Early Recurrence of Hepatocellular Carcinoma Eligible for Curative Ablation: A Multicenter Cohort Study.
    J Comput Assist Tomogr. 2025 May 6. doi: 10.1097/RCT.0000000000001764.
    

    >> Share

    
    

    
    J Hepatol

27. AM FULGENZI C, Dalla Pria A, Leone AG, Celsa C, et al
    Hepatocellular carcinoma in people living with HIV.
    J Hepatol. 2025 Apr 30:S0168-8278(25)00287-9. doi: 10.1016/j.jhep.2025.
    

    >> Share

    
    

    
    Oncogene

28. SHU Y, Tao Q, Xu Q, Chen Y, et al
    Loss of NUMB promotes hepatomegaly and hepatocellular carcinoma through the AKT/glycogen/hippo signaling.
    Oncogene. 2025 May 3. doi: 10.1038/s41388-025-03430.
    

    >> Share

    
    

    
    PLoS One

29. HJORTH M, Forsberg A
    Predictive factors for limited health literacy among persons with cirrhosis: A Swedish explorative cross-sectional study.
    PLoS One. 2025;20:e0321780.
    

    >> Share

    
    
30. YANG J, Zhou Z
    Analysis and study of risk factors related to the progression of non-alcoholic fatty liver disease: A retrospective cohort study.
    PLoS One. 2025;20:e0322990.
    

    >> Share

    
    
31. XIE L, Huang L, Fang X, Zha J, et al
    Assessing Liver Function in Rat Models of Acute Liver Failure Using Single-Photon Emission Computed Tomography and Cytokine Levels.
    PLoS One. 2025;20:e0323531.
    

    >> Share

    
    
32. HOU W, Zou T, Yan Y, Zhuang Y, et al
    5-O-Methylvisammioside inhibits HMGB1-induced Angiogenesis of hepatocellular carcinoma through RAGE/MEK/ERK signaling pathway.
    PLoS One. 2025;20:e0322056.
    

    >> Share

    
    
33. ZHANG Y, Zhang H, Liu L
    Integration of single-cell and bulk RNA sequencing identifies and validates T cell-related prognostic model in hepatocellular carcinoma.
    PLoS One. 2025;20:e0322706.
    

    >> Share

    
    

    
    Pol J Radiol

34. MA S, Zhu Y, Pu C, Li J, et al
    Computed tomography radiomics combined with clinical parameters for hepatocellular carcinoma differentiation: a machine learning investigation.
    Pol J Radiol. 2025;90:e140-e150.
    

    >> Share

    
    

    
    Radiology

35. LIU H, Fan W, Li H, Qiao L, et al
    Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial.
    Radiology. 2025;315:e242315.
    

    >> Share

    
    

    
    Transplantation

36. XIE C, Qiu N, Wang C, Chen J, et al
    G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression.
    Transplantation. 2025 May 8. doi: 10.1097/TP.0000000000005412.
    

    >> Share

    
    
37. MONTI C, Hong SK, Lee A, Hong JC, et al
    Acute Response of Hepatocyte MRP2 Internalization as an Indicator of Ischemia-Reperfusion Injury in Liver Transplantation.
    Transplantation. 2025 May 5. doi: 10.1097/TP.0000000000005418.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share